- 现金
- 20661 元
- 精华
- 7
- 帖子
- 12793
- 注册时间
- 2013-12-29
- 最后登录
- 2024-11-2
|
TetraLogic Announces Termination of Public Offering
MALVERN, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced termination of the underwriting agreement for and cancellation of its previously announced underwritten public offering of 6.25 million shares of the Company's common stock at a price to the public of $4.00 per share |
|